Physician profile
John P Loftus
NPI 1922074319
$8,943.33
in general payments reported to CMS, 2019-2025
12 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,637 · 2020: $11.74 · 2021: $365 · 2022: $310 · 2023: $162 · 2024: $1,225 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138 · Travel and Lodging: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,138.43 |
| Travel and Lodging | $481.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $6,448.30 | 2019 | |
| Penumbra, INC. | $1,211.75 | 2024 | Indigo System, Penumbra System |
| Medtronic, INC. | $796.00 | 2021-2023 | In.Pact Admiral |
| Shockwave Medical, INC | $213.93 | 2025 | |
| Osiris Therapeutics INC. | $121.13 | 2019 | |
| Boston Scientific Corporation | $40.92 | 2023 | Eluvia |
| Intuitive Surgical, INC. | $38.68 | 2019 | |
| Angiodynamics, INC. | $27.88 | 2019-2024 | Auryon Laser System 100-120 Vac |
| Mimedx Group, INC. | $19.05 | 2025 | |
| Acell, INC. | $13.95 | 2019 | |
| Smith+Nephew, INC. | $11.74 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Loftus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.